Skip to main content

The Mark Foundation for Cancer Research (US) Ltd

New York, New York·EIN 36-4825921·NTEE G30 · Diseases, Disorders & Medical Disciplines·501(c)(3)·Filing year 2024

The Mark Foundation for Cancer Research (US) Ltd's highest-paid officer, the Chief Executive Officer, was reported at $561,364 for 2024 (IRS Form 990), including base pay and other compensation. Reported CEO pay ranged from $554,536 to $561,364 between 2023 and 2024.

Total revenue
$44.8M
Total assets
$105.5M
Total expenses
$36.1M
Reported officers
14

How The Mark Foundation for Cancer Research (US) Ltd’s pay compares

Compared with Diseases, Disorders & Medical Disciplines organizations of similar size in New York.

In line with peers

Most of the roles The Mark Foundation for Cancer Research (US) Ltd reports are paid within the middle half of what these Diseases, Disorders & Medical Disciplines organizations pay for the same roles.

Show how each role compares

From the officer pay The Mark Foundation for Cancer Research (US) Ltd reported on its latest IRS Form 990.

PARTNER WITH SCIENTISTS TO ACCELERATE RESEARCH THAT WILL TRANSFORM THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CANCER THROUGH GROUND BREAKING SCIENCE CARRIED OUT BY INDIVIDUAL INVESTIGATORS, MULTIDISCIPLINARY TEAMS, AND EARLY STAGE COMPANIES IN THE U.S AND ABROAD.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 10 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Diseases, Disorders & Medical Disciplines organizations of similar size in New York.

Chief Executive Officer
Above 90th percentile
$561k
Base
$364k
Bonus
$142k
Other
—
Benefits
$43k
Executive Chairman of the Board
Board Chair
$560k
Base
$560k
Bonus
—
Other
—
Benefits
—
Head Discovery/pre-clinical Research
Highest Compensated Employee
$362k
Base
$255k
Bonus
$56k
Other
—
Benefits
$43k
Principal, Venture Investments
Key Employee
Median to 75th percentileOn the typical range for this role
$349k
Base
$164k
Bonus
$48k
Other
$116k
Benefits
$17k
Head of Development
Highest Compensated Employee
$247k
Base
$193k
Bonus
$23k
Other
—
Benefits
$27k
Director, Grants Administration
Highest Compensated Employee
$232k
Base
$168k
Bonus
$29k
Other
—
Benefits
$28k
Senior Scientific Director
Highest Compensated Employee
$223k
Base
$151k
Bonus
$25k
Other
—
Benefits
$42k
Director Finance & Administration
25th percentile to median
$216k
Base
$166k
Bonus
$7k
Other
—
Benefits
$43k
Associate Scientific Director
Highest Compensated Employee
$190k
Base
$143k
Bonus
$27k
Other
—
Benefits
$15k
Director
Board Member
$10k

Plus 4 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines →

Top pay as a share of expenses

In 2024, the highest total compensation at The Mark Foundation for Cancer Research (US) Ltd equaled 2% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

This organization (2024)
2%
Sector median
10%
Middle half of sector
4% to 22%

Based on 2,390 diseases, disorders & medical disciplines organizations, each measured at its most recent filing year with reported expenses and compensation.

Held steady
from 2023

From $560k in 2023 to $561k in 2024.

$560k
2023
$561k
2024
Pay for the position

Chief Executive Officer pay rose 1% from 2023 to 2024, while revenue rose 9%.

$555k in 2023 to $561k in 2024.
  • Board Chair pay held roughly steady from 2023 to 2024.
  • Highest Compensated Employee pay fell 2% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Common questions about The Mark Foundation for Cancer Research (US) Ltd

What does the Chief Executive Officer of The Mark Foundation for Cancer Research (US) Ltd earn?

In 2024, the Chief Executive Officer of The Mark Foundation for Cancer Research (US) Ltd received $561,364 in total compensation. This pay is in the top 10% for Chief Executive Officer roles among Diseases, Disorders & Medical Disciplines organizations of similar size in New York: at least 9 in 10 comparable filings report less. Based on IRS Form 990 data.

How does Chief Executive Officer pay at The Mark Foundation for Cancer Research (US) Ltd compare with similar nonprofits?

Compared with the same role at Diseases, Disorders & Medical Disciplines organizations of similar size in New York, the 2024 pay of the Chief Executive Officer at The Mark Foundation for Cancer Research (US) Ltd falls in the top 10%. In 2024, the highest total compensation at The Mark Foundation for Cancer Research (US) Ltd equaled 2% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

What are The Mark Foundation for Cancer Research (US) Ltd's revenue and expenses?

In 2024, The Mark Foundation for Cancer Research (US) Ltd reported $44.8M in total revenue and $36.1M in total expenses on its IRS Form 990.